The “Future Pharma Connect” event series has established itself as a permanent fixture in the industry dialog of the pharma, biotech and medtech industry in 2025. The event format initiated by Inizio Engage has stood for open exchange, practical insights and sustainable networking at eye level for several years. Whether as a live event or online format, Future Pharma Connect brings together decision-makers, experts and opinion leaders to shape the future of the healthcare industry together.
What makes the series special is the clear focus on relevant business issues along the entire value chain – from data-driven sales, market access and patient solutions to artificial intelligence and omnichannel strategies. The focus is primarily on personal exchange: experts come together, share practical experiences, discuss openly at eye level and make valuable contacts. Instead of buzzwords, the event is characterized by best practices and honest discussions.
“The best strategies are developed through open exchange with people who face the same challenges every day. Future Pharma Connect creates precisely this space – practical, honest and with real added value for the business.” – Dr. Dietmar Röleke, Inizio Engage
A recurring core topic of the event series is the transformation of pharmaceutical sales. Insights from Insight Health and Moderna, among others, showed how data-driven strategies can be successfully implemented today. Real-life case studies were used to illustrate how market and competitive analyses, precise HCP profiling and AI-based platforms help to deploy sales resources more efficiently and optimize decisions along the customer journey.
Particularly relevant: The use of machine learning and predictive analytics does not end with segmentation, but influences the planning, management and performance measurement of launches as well as continuous sales optimization in the post-launch phase.
In addition to commercial excellence, patient engagement is increasingly becoming the focus of strategic discussions. At several Future Pharma Connects – including accompanying specialist congresses – there was intensive discussion about how patient-centric support programs can create real added value.
Practical examples from AbbVie and Inizio Engage showed how patient support programs, concierge services and data-based solutions not only improve therapy adherence and care, but also enable trust, access and differentiation in the market. “Patient partnership” thus becomes a measurable competitive advantage – especially for complex therapies and in rare diseases.
Future Pharma Connect is deliberately designed as an interactive platform: compact impulses, open discussions and intensive networking in a personal atmosphere – both online and offline. Whether breakfast format, workshop or after-work event: the added value comes from the exchange between like-minded people from Market Access, Medical, Commercial, Pricing and Management.
*This text was created with the help of AI
Jump to a slide with the slide dots.
CASE STUDY (US) Strategic partnership to re-evaluate resources required to drive quality and execution
Read more
CASE STUDY (US) Flexibility and impact through Rapid Deployment Representative specialty team.
Read more
CASE STUDY (Canada) See how Inizio Engage helped a leading OTC brand protect market share and drive HCP advocacy through targeted field and virtual...
Read more
Discover how partnership-led pharma commercialization strategies drive better HCP engagement, agility, and performance in an AI-enabled world.
Read more